Organon (OGN) Interest Expenses (2021 - 2026)

Organon (OGN) recorded quarterly Interest Expenses of $111.0 million in Q1 2026, down 8.26% quarter-over-quarter from $121.0 million in Q4 2025, and down 10.48% on a YoY basis from $124.0 million in Q1 2025.

Organon (OGN) Interest Expenses (2021 - 2026) Analysis & Trends

Organon's Interest Expenses history runs 6 years deep, the most recent figure standing at $111.0 million for Q1 2026.

  • In Q1 2026, Interest Expenses fell 10.48% year-over-year to $111.0 million; the TTM figure through Mar 2026 stood at $491.0 million (down 4.29% YoY), while the FY2025 annual figure was $504.0 million, down 3.08% from the prior year.
  • Interest Expenses was $111.0 million for Q1 2026 at Organon, down from $121.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $134.0 million in Q3 2023 to a low of $97.0 million in Q1 2022.
  • Historically, Interest Expenses has averaged $122.6 million across 5 years, with a median of $128.0 million in 2025.
  • The sharpest annual moves came in 2022 and 2026: Interest Expenses soared 58.06% in 2022, then dropped 10.48% in 2026.
  • A 5-year view of Interest Expenses shows it stood at $119.0 million in 2022, then increased by 8.4% to $129.0 million in 2023, then increased by 2.33% to $132.0 million in 2024, then retreated by 8.33% to $121.0 million in 2025, then retreated by 8.26% to $111.0 million in 2026.
  • The last three Interest Expenses figures came in at $111.0 million (Q1 2026), $121.0 million (Q4 2025), and $128.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -225.15 Mn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn -
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 272.00 Mn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn -
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 657.00 Mn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 240.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 111.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 111.00 Mn
Mar 31, 2026 111.00 Mn
Dec 31, 2025 121.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 128.00 Mn
Sep 30, 2025 128.00 Mn
Jun 30, 2025 131.00 Mn
Jun 30, 2025 131.00 Mn
Mar 31, 2025 124.00 Mn
Mar 31, 2025 124.00 Mn
Dec 31, 2024 132.00 Mn
Dec 31, 2024 132.00 Mn
Sep 30, 2024 126.00 Mn
Sep 30, 2024 126.00 Mn
Jun 30, 2024 131.00 Mn
Jun 30, 2024 131.00 Mn
Mar 31, 2024 131.00 Mn
Mar 31, 2024 131.00 Mn
Dec 31, 2023 129.00 Mn
Dec 31, 2023 129.00 Mn